Respiratory Disease News

Medindia's Press Release’ section provides the latest press release on Respiratory Disease from across the world for the global audience. This page links to 843 Respiratory Disease press releases.

Newly Developed RSV Vaccine Offers Immunity While Lowering the Risk of Dangerous Pulmonary Inflammation

Promising results of preclinical research on a fully synthetic vaccine designed by Artificial Cell Technologies are published in the journal Vaccines NEW HAVEN, Conn. , Jan. 30, 2023 /PRNewswire/ -- Scientists at Artificial Cell ...


Leveraging Rapid Multiplex Testing During the Height of Respiratory Season, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn about the benefits of multiplex respiratory panels tests for patient management, especially in the context of antimicrobial stewardship initiatives. Attendees will understand clinical situations in which a lowplex ...

Rimidi Showcases New Module for Respiratory Disease Management at HLTH 2022, Designed to Deliver Better Treatment Decisions

Via an integration with Teva Pharmaceuticals, the new module will leverage digital therapeutics to improve outcomes for patients with respiratory diseases ATLANTA , Nov. 17, 2022 /PRNewswire-PRWeb/ -- Rimidi , a leading clinical ...

Boehringer Ingelheim Welcomes New 2023 GOLD Report Positioning LAMA/LABA as the Preferred Treatment for the Majority of Patients with COPD

The 2023 GOLD Report recommends LAMA, LABA or LAMA+LABA therapy as the initial treatment for patients with COPD Based on GOLD criteria, a LAMA/LABA, such as STIOLTO ® RESPIMAT ® , is now the optimal first-line treatment for most patients ...

Chronic Obstructive Pulmonary Disease (COPD) Market Expected to Reach $25 Billion By 2027

FinancialNewsMedia.com News Commentary PALM BEACH, Fla , Nov. 15, 2022 /PRNewswire/ -- Chronic obstructive pulmonary disease is a chronic lung disease that prevents airflow from the lungs. The rising incidence of COPD is one ...

Phase 2a Trial for EP395 in Chronic Obstructive Pulmonary Disease (COPD) Patients

EpiEndo Pharmaceuticals (EpiEndo) the clinical-stage biopharmaceutical company developing therapeutics for chronic inflammatory diseases has received regulatory approval to commence a Phase 2a clinical trial with lead molecule EP395 in COPD (Chronic ...

Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China

SHANGHAI , Nov. 13, 2022 /PRNewswire/ -- Nuance Pharma ("the Company") announces the Center for Drug Evaluation ("CDE") has approved its Investigational New Drug ("IND") application supporting its pivotal phase III clinical trial of ...

Bridge Biotherapeutics Initiates Phase 2 Clinical Trial of BBT-877 in Patients with Idiopathic Pulmonary Fibrosis

The Phase 2 study will evaluate the efficacy, safety, and tolerability of BBT-877 in idiopathic pulmonary fibrosis patients Data from the Phase 1 clinical study demonstrated LPA inhibition of up to 90 percent, which is expected to ...

Top NYC Otolaryngologist Dr. Gregory Levitin Has Developed a Unique, Needle-Free Approach to Successful Office Balloon Sinuplasty

Dr. Levitin is widely known as a foremost authority on balloon sinuplasty treatment and has been performing this procedure for over 15 years. NEW YORK , Oct. 24, 2022 /PRNewswire-PRWeb/ -- Dr. Gregory Levitin performs over 100 ...

AeroRx Partners with HCmed to Develop a Nebulized LABA/LAMA Combination Solution for the Treatment of Chronic Obstructive Pulmonary Disease

TAIPEI , Oct. 2, 2022 /PRNewswire/ -- AeroRx Therapeutics, LLC. (AeroRx) and HCmed Innovations Co., Ltd. (HCmed) have initiated a collaboration, introducing a LABA/LAMA combination solution for delivery with a breath-actuated nebulizer. ...

Respiratory Disease News »

Undernourished Household Members at Higher TB Risk Post-Exposure

Undernourished Household Members at Higher TB Risk Post-Exposure

In a recent study tracking household contacts (individuals residing in the same dwelling) of tuberculosis (TB) patients, researchers discovered that undernourished contacts were three times more likely to develop TB disease. Interestingly, the study ...

Influenza: Top Concern Among Global Infectious Disease Experts

Influenza: Top Concern Among Global Infectious Disease Experts

Recent findings presented at the ESCMID Global Congress in Barcelona reveal that in a survey conducted by the VACCELERATE Consortium, infectious diseases experts ranked pathogens based on pandemic potential. The study identified influenza as the ...

Whooping Cough Spreading in China: 13 Deaths in 2 Months Raise Alarm

Whooping Cough Spreading in China: 13 Deaths in 2 Months Raise Alarm

Whooping cough, also known as pertussis , has emerged as a concerning health issue in China, with reports indicating 13 deaths within a span of just two months. This resurgence of the bacterial infection has sparked widespread ...

Long-Term Lung Effects After Tuberculosis Treatment

Long-Term Lung Effects After Tuberculosis Treatment

New research being presented at this year’s ESCMID Global Congress in Barcelona, Spain (27-30 April) suggests that tuberculosis (TB) can have long-term effects on the lungs of individuals who have been successfully treated for the ...

No COVID-19 Link to Childhood Asthma Development

No COVID-19 Link to Childhood Asthma Development

A SARS-CoV-2 infection does not significantly heighten the risk of asthma development in pediatric patients, stated study published in the journal Pediatrics ( ). Respiratory viral infections early in life are risk factors for asthma. ...

More Respiratory Disease News

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.